MedTrace Logo

Gabapentin Dosages for Postoperative Analgesia Following Open Thoracotomy

NCT05172570 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-03-21

Study results available
· View outcomes & findings →

Summary

Gabapentin is a nerve medication that treats pain. The specific aim of the study is to compare the difference in the postoperative use of no gabapentin, 300 mg gabapentin 3x daily, or 300 mg gabapentin once at night. Our hypothesis is that higher doses of gabapentin will correlate with decreased pain at the incision and chest tube sites and decreased opioid consumption.

Conditions

  • Thoracotomy
  • Pain, Postoperative

Interventions

DRUG

Gabapentin

Gabapentin is a common medication used preoperatively and postoperatively as part of multimodal analgesia to help with acute pain.

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Yar Yeap, MD · Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-06
Primary Completion
2022-02-25
Completion
2022-03-02
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05172570 on ClinicalTrials.gov